This page shows the latest European approvals 2019 news and features for those working in and with pharma, biotech and healthcare.
few weeks after Esperoct was cleared by the FDA, and Novo Nordisk says it will start launching it in the EU in the second half of 2019. ... The EU and US approvals of Esperoct are based on data from a trial which included 270 previously treated people
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...